Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bastholt

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
Journal of Medical Internet Research|April 10, 2020
Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients' and Clinicians' ExperiencesLærke K Tolstrup, Helle Pappot, Lars Bastholt, et al.
European Journal of Cancer (Oxford, England : 1990)|May 21, 2019
High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohortLars Bastholt, Inge Marie Svane, Jon Kroll Bjerregaard, et al.
Cancer Immunology, Immunotherapy : CII|December 3, 2014
Fever and the use of paracetamol during IL-2-based immunotherapy in metastatic melanomaAnne Helene Køstner, Mai-Britt Bjørklund Ellegaard, Ib Jarle Christensen, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2023
Health care and socioeconomic costs for long-term survivors after implementation of checkpoint-inhibitors and targeted agents for metastatic melanomaAnne Vest Soerensen, Jakob Kjellberg, Rikke Ibsen, et al.
Melanoma Research|May 24, 2012
Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanomaLise Hoejberg, Lars Bastholt, Julia S Johansen, et al.
Cancers|September 16, 2020
Improved Progression-Free Long-Term Survival of a Nation-Wide Patient Population with Metastatic MelanomaAnne Vest Soerensen, Eva Ellebaek, Lars Bastholt, et al.
Ugeskrift for Laeger|March 17, 2009
[Mini clinical evaluation exercise as evaluation tool of communicative and cooperative skills in the outpatient clinic]Jesper Grau Eriksen, Dorit Simonsen, Lars Bastholt, et al.
Health and Quality of Life Outcomes|April 29, 2018
Danish translation, cultural adaption and initial psychometric evaluation of the patient feedback formLærke K Tolstrup, Helle Pappot, Graziella Zangger, et al.
Oncoimmunology|May 4, 2018
Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumabAnders H Kverneland, Christian Enevold, Marco Donia, et al.
Hypertension (Dallas, Tex. : 1979)|January 10, 2018
Pazopanib-Induced Hypertension in Patients With Renal Cell Carcinoma Is Associated With Low Urine Excretion of NO MetabolitesAnne Robdrup Tinning, Camilla Bengtsen, Niels Viggo Jensen, et al.
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Journal of Medical Internet Research|April 10, 2020
Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients' and Clinicians' ExperiencesLærke K Tolstrup, Helle Pappot, Lars Bastholt, et al.
European Journal of Cancer (Oxford, England : 1990)|May 21, 2019
High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohortLars Bastholt, Inge Marie Svane, Jon Kroll Bjerregaard, et al.
Cancer Immunology, Immunotherapy : CII|December 3, 2014
Fever and the use of paracetamol during IL-2-based immunotherapy in metastatic melanomaAnne Helene Køstner, Mai-Britt Bjørklund Ellegaard, Ib Jarle Christensen, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2023
Health care and socioeconomic costs for long-term survivors after implementation of checkpoint-inhibitors and targeted agents for metastatic melanomaAnne Vest Soerensen, Jakob Kjellberg, Rikke Ibsen, et al.
Melanoma Research|May 24, 2012
Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanomaLise Hoejberg, Lars Bastholt, Julia S Johansen, et al.
Cancers|September 16, 2020
Improved Progression-Free Long-Term Survival of a Nation-Wide Patient Population with Metastatic MelanomaAnne Vest Soerensen, Eva Ellebaek, Lars Bastholt, et al.
Ugeskrift for Laeger|March 17, 2009
[Mini clinical evaluation exercise as evaluation tool of communicative and cooperative skills in the outpatient clinic]Jesper Grau Eriksen, Dorit Simonsen, Lars Bastholt, et al.
Health and Quality of Life Outcomes|April 29, 2018
Danish translation, cultural adaption and initial psychometric evaluation of the patient feedback formLærke K Tolstrup, Helle Pappot, Graziella Zangger, et al.
Oncoimmunology|May 4, 2018
Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumabAnders H Kverneland, Christian Enevold, Marco Donia, et al.
Hypertension (Dallas, Tex. : 1979)|January 10, 2018
Pazopanib-Induced Hypertension in Patients With Renal Cell Carcinoma Is Associated With Low Urine Excretion of NO MetabolitesAnne Robdrup Tinning, Camilla Bengtsen, Niels Viggo Jensen, et al.
Pageof 14